Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Interest Coverage Ratio of 0.85 for Q1 2026, down 454.39% on a QoQ basis from 0.24 in Q4 2025, and down 104.84% year-over-year from 17.62 in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 0.85 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 104.84% year-over-year to 0.85 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.34 (up 42.98% YoY) and the FY2025 annual result came in at 1.1, up 182.19% from the prior year.
- Interest Coverage Ratio was 0.85 for Q1 2026 at Arrowhead Pharmaceuticals, down from 0.24 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 19.14 in Q1 2022 and bottomed at 77.39 in Q3 2024.
- A 5-year average of 13.26 and a median of 7.46 in 2024 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 11984.06% in 2022, while the deepest fall reached 30135.34% in 2022.
- Arrowhead Pharmaceuticals' Interest Coverage Ratio stood at 14.79 in 2022, then tumbled by 72.03% to 25.44 in 2023, then jumped by 70.69% to 7.46 in 2024, then jumped by 103.23% to 0.24 in 2025, then tumbled by 454.39% to 0.85 in 2026.
- Business Quant data shows ARWR's Interest Coverage Ratio at 0.85 in Q1 2026, 0.24 in Q4 2025, and 10.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.85 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | -10.16 |
| Jun 30, 2025 | -0.94 |
| Mar 31, 2025 | 17.62 |
| Dec 31, 2024 | -7.46 |
| Sep 30, 2024 | -77.39 |
| Jun 30, 2024 | -34.58 |
| Mar 31, 2024 | -17.42 |
| Dec 31, 2023 | -25.44 |
| Sep 30, 2023 | 9.97 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | 9.52 |
| Dec 31, 2022 | -14.79 |
| Sep 30, 2022 | -49.31 |
| Jun 30, 2022 | -42.89 |
| Mar 31, 2022 | 19.14 |
| Dec 31, 2021 | -0.42 |
| Sep 30, 2021 | -72.09 |
| Jun 30, 2021 | -0.14 |